文献速递生殖医学

先天性低促性腺激素性性腺功能减退症患者中ANOS1突变遗传谱的扩展

Expanding the genetic spectrum of ANOS1 mutations in patients with congenital hypogonadotropic hypogonadism.
PubMed 文献 · Hum Reprod · 2017-01-01

这项横断面研究纳入42例无亲缘关系的男性先天性低促性腺激素性性腺功能减退症(CHH)患者,其中Kallmann综合征(KS)20例、嗅觉正常型CHH 22例,通过DNA测序筛查ANOS1基因突变。3例(7.1%)KS患者检出半合子突变,包括一处导致外显子跳跃的新发剪接位点突变、一处复发性无义突变及一处涉及ANOS1等九个基因的新发4.8 Mb缺失。

要点

  • 42例CHH男性中3例(7.1%)检出ANOS1半合子突变,均为KS病例。
  • 新发剪接位点突变c.542-1G>C导致ANOS1转录本外显子5跳跃。
  • 新发4.8 Mb缺失涉及ANOS1及VCX3B、VCX2、PNPLA4、VCX、STS、HDHD1、VCX3A和NLGN4X八个其他基因。

核心结论

  • 本研究扩展了与CHH相关的已知遗传缺陷谱,并提示自报嗅觉功能正常的患者不应被排除在ANOS1基因检测之外。

研究设计与样本

  • 横断面研究纳入42例无亲缘关系的CHH男性,其中KS 20例、嗅觉正常型CHH 22例。
  • 通过DNA测序筛查ANOS1基因突变,所检出突变进一步用RT-PCR分析及多重连接依赖探针扩增(MLPA)分析验证。

主要发现

  • 3例(7.1%)KS病例检出半合子突变:一例为自报嗅觉正常(检测时为嗅觉减退)患者的新发剪接接受位点突变c.542-1G>C,导致ANOS1转录本外显子5跳跃。
  • 一例为复发性无义突变c.571C>T(p.Arg191*)。
  • 一例为伴鱼鳞病的KS患者的新发4.8 Mb缺失,涉及ANOS1及VCX3B、VCX2、PNPLA4、VCX、STS、HDHD1、VCX3A和NLGN4X八个其他基因。

临床怎么用

  • 作者认为,自报嗅觉功能正常的患者不应被排除在ANOS1基因检测之外。

局限性

  • 并非所有自报嗅觉正常的病例都进行了客观嗅觉测试,这可能低估了嗅觉缺陷。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: What is the prevalence and functional consequence of ANOS1 (KAL1) mutations in a group of men with congenital hypogonadotropic hypogonadism (CHH)? SUMMARY ANSWER: Three of forty-two (7.1%) patients presented ANOS1 mutations, including a novel splice site mutation leading to exon skipping and a novel contiguous gene deletion associated with ichthyosis. WHAT IS KNOWN ALREADY: CHH is characterized by lack of pubertal development and infertility, due to deficient production, secretion or action of GnRH, and can be associated with anosmia/hyposmia (Kallmann syndrome, KS) or with a normal sense of smell (normosmic CHH). Mutations in the anosmin-1 (ANOS1) gene are responsible for the X-linked recessive form of KS. STUDY DESIGN, SIZE, DURATION: This cross-sectional study included 42 unrelated men with CHH (20 with KS and 22 with normosmic CHH). PARTICIPANTS/MATERIALS, SETTING, METHODS: Patients were screened for mutations in the ANOS1 gene by DNA sequencing. Identified mutations were further investigated by RT-PCR analysis and multiplex ligation-dependent probe amplification (MLPA) analysis. MAIN RESULTS AND THE ROLE OF CHANCE: Hemizygous mutations were identified in three (7.1%) KS cases: a novel splice acceptor site mutation (c.542-1G>C), leading to skipping of exon 5 in the ANOS1 transcript in a patient with self-reported normosmia (but hyposmic upon testing); a recurrent nonsense mutation (c.571C>T, p.Arg191*); and a novel 4.8 Mb deletion involving ANOS1 and eight other genes (VCX3B, VCX2, PNPLA4, VCX, STS, HDHD1, VCX3A and NLGN4X) in KS associated with ichthyosis. LIMITATIONS, REASONS FOR CAUTION: Objective olfactory testing was not performed in all cases of self-reported normosmia and this may have underestimated the olfactory deficits. WIDER IMPLICATIONS OF THE FINDINGS: This study further expands the spectrum of known genetic defects associated with CHH and suggests that patients with self-reported normal olfactory function should not be excluded from ANOS1 genetic testing. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by the Portuguese Foundation for Science and Technology. The authors have no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Gonçalves CI, Fonseca F, Borges T, et al. Expanding the genetic spectrum of ANOS1 mutations in patients with congenital hypogonadotropic hypogonadism. Hum Reprod. 2017. PMID: 28122887. doi:10.1093/humrep/dew354

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。